Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Also known as Red Light (PDT)
Red Light · 1 trial · 1 indication
Adverse events and local tolerability assessed at pre and immediately post treatment, at Day 1 and Day 7 following treatment.
| Arm | Type | Description |
|---|---|---|
| Red light dose (PDT) 75 J/cm2 | OTHER | Subjects in Cohort 1 will receive active and vehicle solution followed by a red light dose of 75 J/cm2 at 25 mW/cm2 |
| Red Light (PDT) 150 J/cm2 | OTHER | Subjects in Cohort 2 will receive active and vehicle solution followed by a red light dose of 150 J/cm2 at 40 mW/cm2 |
| Name | Type | Description |
|---|---|---|
| Red Light (PDT) | DRUG | LTS, 0.3% applied topically followed by red light dose (75 J/cm2 or 150 J/cm2) |
Inclusion Criteria: 1. Healthy adults 18 years of age or older 2. Fitzpatrick skin types I-IV Exclusion Criteria: 1. Current pregnancy or lactation. 2. Presence of severe facial acne, acne fulminans or conglobata, or nodulocystic acne. 3. Poor skin condition on the back, including erythema, dryne...
Red Light is being developed for the treatment of acne vulgaris, a common dermatological condition. It is an investigational small molecule therapy that has been studied in a Phase 1 clinical trial. It is not yet approved for any indication.
Red Light is being developed by Eli Lilly and Company, which trades on the New York Stock Exchange under the ticker symbol LLY. The company is responsible for the clinical development program for this asset.
Red Light is in Phase 1 clinical development. One Phase 1 trial has been completed, and no active trials are currently listed. It remains an investigational therapy and has not received regulatory approval for any indication.
Red Light has been evaluated in a single Phase 1 trial, NCT01830764, titled an open-label safety and tolerability study of LTS-PDT in healthy volunteers. The trial enrolled 12 participants in the United States and has been completed.
Yes, Red Light is also known as Red Light (PDT). The abbreviation PDT refers to photodynamic therapy, which is the approach used in its development. Both names refer to the same investigational asset being studied for acne vulgaris.